Budesonide for inhalation is generally referred to as a suspension, a topical nebulized inhalation preparation that improves symptoms associated with bronchial asthma and asthmatic chronic bronchitis.
Budesonide Suspension for Inhalation may be used as an alternative to, or to reduce, oral steroid therapy in patients with bronchial asthma and asthmatic chronic bronchitis. Budesonide inhibits the immune response and decreases antibody synthesis, and attenuates the contractile response of smooth muscle by inhibiting the synthesis and release of bronchoconstrictor substances.
Adverse reactions such as allergic reactions, chest pain, fatigue, and flu-like symptoms may occur after administration of Budesonide Suspension for Inhalation.
It is important to note that budesonide is contraindicated in individuals with hypersensitivity to budesonide or milk proteins; use with caution in athletes.
Inhalation therapy with glucocorticoids instead of oral therapy may sometimes result in symptoms previously masked by oral glucocorticoid therapy, such as allergic rhinitis, eczema, myalgia, or arthralgia, for which symptomatic treatment should be given.
The above medications should be used under the supervision of a physician, and specific treatment regimens should be followed by a physician for better treatment of the disease.